140 results
Page 3 of 7
POSASR
EX-5.1
ig3 yzzctxnefelto6fv
30 Mar 22
Automatic shelf registration (post-effective amendment)
7:57am
POSASR
fwgqp3gusz82x4
30 Mar 22
Automatic shelf registration (post-effective amendment)
7:57am
8-K
EX-99.1
p62elzemhcar11jvnb
14 Sep 21
Orchard Therapeutics Bolsters R&D and Technical Operations Leadership with New Executive Appointments
7:00am
S-8
EX-5.1
eimgokpvy4hk60b6a
4 Aug 21
Registration of securities for employees
4:06pm
8-K
EX-99.1
ed1jnn3y89he2cg9hni
4 Aug 21
Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Updates
7:05am
8-K
EX-99.1
xzy2zzt
1 Jul 21
Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new and larger indications
5:02pm
8-K
mgtugo44l5uon po
1 Jul 21
Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new and larger indications
5:02pm